BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7312083)

  • 1. Iron absorption in patients on regular dialysis therapy.
    Bezwoda WR; Derman DP; Bothwell TH; MacPhail AP; Torrance JD; Milne FJ; Meyers AM; Levin J
    Nephron; 1981; 28(6):289-93. PubMed ID: 7312083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of erythropoietin therapy on iron absorption in chronic renal failure.
    Skikne BS; Ahluwalia N; Fergusson B; Chonko A; Cook JD
    J Lab Clin Med; 2000 Jun; 135(6):452-8. PubMed ID: 10850644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum ferritin and bone marrow iron in patients undergoing continuous ambulatory peritoneal dialysis.
    Blumberg AB; Marti HR; Graber CG
    JAMA; 1983 Dec 23-30; 250(24):3317-9. PubMed ID: 6645029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron absorption measured by whole body counting and the relation to marrow iron stores in chronic uremia.
    Milman N
    Clin Nephrol; 1982 Feb; 17(2):77-81. PubMed ID: 6802544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The iron reserve status in patients on regular dialysis treatment].
    Zadrazil J; Papajík T; Scudla V; Jezáková J; Budíková M; Slavícek J
    Vnitr Lek; 1991 Apr; 37(4):369-75. PubMed ID: 2053308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative contributions of body iron status and uremia severity to anemia in patients with advanced chronic renal failure.
    Ifudu O; Dawood M; Friedman EA
    Nephron; 1997; 77(3):315-8. PubMed ID: 9375826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum ferritin assay and iron status in chronic renal failure and haemodialysis.
    Hussein S; Prieto J; O'Shea M; Hoffbrand AV; Baillod RA; Moorhead JF
    Br Med J; 1975 Mar; 1(5957):546-8. PubMed ID: 49205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Iron absorption in undialysed patients with chronic renal insufficiency, patients undergoing regular hemodialysis and patients with renal transplants].
    Milman N; Larsen L
    Ugeskr Laeger; 1977 Jan; 139(3):135-9. PubMed ID: 318779
    [No Abstract]   [Full Text] [Related]  

  • 9. Iron stores in patients on haemodialysis after renal transplantation.
    John GT; Chandy M; Thomas PP; Shastry JC; Jacob CK
    Natl Med J India; 1993; 6(3):108-10. PubMed ID: 8329987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral iron absorption in hemodialysis patients treated with erythropoietin.
    Donnelly SM; Posen GA; Ali MA
    Clin Invest Med; 1991 Aug; 14(4):271-6. PubMed ID: 1782724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron metabolism in haemodialysis patients. A study of the management of iron therapy and overload.
    Gokal R; Millard PR; Weatherall DJ; Callender ST; Ledingham JG; Oliver DO
    Q J Med; 1979 Jul; 48(191):369-91. PubMed ID: 542584
    [No Abstract]   [Full Text] [Related]  

  • 12. Hematologic parameters and iron stores in patients on hemodialysis for chronic renal failure.
    Nuwayri-Salti N; Jabre F; Daouk M; Sa'ab G; Salem Z
    Clin Nephrol; 1992 Aug; 38(2):101-4. PubMed ID: 1516277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitating iron balance in hemodialysis patients.
    Eschbach JW; Cook JD
    Trans Am Soc Artif Intern Organs; 1977; 23():54-8. PubMed ID: 910378
    [No Abstract]   [Full Text] [Related]  

  • 14. Iron absorption in non-dialysed patients with chronic renal failure, in patients on regular hemodialysis, and in renal transplanted patients.
    Milman N; Larsen L
    Dan Med Bull; 1977 Jun; 24(3):108-13. PubMed ID: 330118
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum ferritin in hemodialysis. I. Study in populations treated with iron or untreated].
    Marco Franco JE; Alarcón Zurita A; Morey Molina A; Pizá Buñola C; Bestard Palmer J; Mairata Bosch S; Galmés Llodra A; Dalmau Diana M
    Rev Clin Esp; 1981 Dec; 163(6):403-6. PubMed ID: 7342203
    [No Abstract]   [Full Text] [Related]  

  • 16. Regular low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patients.
    Taylor JE; Peat N; Porter C; Morgan AG
    Nephrol Dial Transplant; 1996 Jun; 11(6):1079-83. PubMed ID: 8671972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum ferritin in haemodialysis.
    Marco-Franco JE; Alarcon A; Morey A; Pizá C; Bestard J; Mairata S; Galmés A; Dalmau M
    Nephron; 1982; 32(1):57-9. PubMed ID: 7177278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum ferritin in renal insufficiency, hemodialysis and kidney transplantation].
    Hofmann V; Descoeudres C; Montandon A; Galeazzi RL; Straub PW
    Schweiz Med Wochenschr; 1978 Nov; 108(47):1835-8. PubMed ID: 362527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum aluminum transport and aluminum uptake in chronic renal failure: role of iron and aluminum metabolism.
    Cannata JB; Olaizola IR; Gomez-Alonso C; Menéndez-Fraga P; Alonso-Suarez M; Diaz-Lopez JB
    Nephron; 1993; 65(1):141-6. PubMed ID: 8413773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of intravenous injection of iron saccharate in haemodialysis patients.
    Sunder-Plassmann G; Hörl WH
    Nephrol Dial Transplant; 1996 Sep; 11(9):1797-802. PubMed ID: 8918625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.